跳至主要内容
临床试验/NCT03868865
NCT03868865已完成不适用

Effects of an Integrative Day-care Clinic Program for Breast Cancer Patients During Chemotherapy: an Observational Study

Universität Duisburg-Essen2 个研究点 分布在 1 个国家目标入组 57 人开始时间: 2012年8月7日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
57
试验地点
2
主要终点
Hospital Anxiety and Depression Scale (HADS)

研究概览

简要总结

The aim of the study was to evaluate a new integrative day-care clinic concept for breast cancer patients receiving chemotherapy. This is an explorative pilot study. Therefore, all outcomes are analyzed exploratively.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • curative malignancy (breast cancer of TNM (T: primary tumor, N: regional nodes, M: metastasis) staging I-III)
  • receiving chemotherapy
  • at least 18 years old
  • written informed consent
  • willing and physically/mentally able to participate in a six hours day care clinic program eleven times during chemotherapy.

排除标准

  • insufficient knowledge of the German language
  • physical or mental disabilities resulting in ineligibility for participation in the program or filling out the questionnaires.

研究组 & 干预措施

Integrative mind-body-medicine group program

Experimental

The 66 hour program encompasses mindfulness training, yoga, moderate exercise, nutrition, naturopathic self-help strategies, cognitive restructuring and acupuncture for the management of side effects caused by chemotherapy.

干预措施: Integrative mind-body-medicine group program (Behavioral)

结局指标

主要结局

Hospital Anxiety and Depression Scale (HADS)

时间窗: up to 26 weeks (depending on chemotherapy regime)

It measures the 2 dimensions anxiety and depression. Scores range from 0 to 21 with higher values indicate higher distress. Values of \>8 indicate potential subclinical anxiety or depressive disorders

Brief Fatigue Inventory (BFI)

时间窗: up to 26 weeks (depending on chemotherapy regime)

BFI has been validated as a short and comprehensive instrument to assess severity of fatigue (three questions) and fatigue-related impairment (six questions) in cancer patients with a 9-item, 11-point rating scale. Higher scores on the BFI correspond to greater severity of fatigue / impairment through fatigue over the past 24 hours.

Satisfaction with the program

时间窗: up to 26 weeks (depending on chemotherapy regime)

Satisfaction was assessed at T1 by 5 questions regarding fulfilled expectations about the program contents, relevance for coping with cancer, social support of the group setting, transferring into everyday life, and recommendation of the program. Each question could be scored from 1=totally agree to 6=totally disagree.

European Organization for Research and Treatment of Cancer (EORTC) QoL questionnaire (QLQ-C30)

时间窗: up to 26 weeks (depending on chemotherapy regime)

Besides the global quality of life subscale, this instrument assesses five functional domains of quality of life: physical, role, emotional, cognitive, and social function. Symptom scales further assess fatigue, pain, nausea and vomiting, dyspnea, insomnia, loss of appetite, constipation, diarrhea, and financial difficulties. Scores of all subscales range from 0 to 100, while a higher score represents a better level of functioning or a worse amount of symptoms.

Patients and numbers of adverse events

时间窗: up to 26 weeks (depending on chemotherapy regime)

All adverse events that occurred during the study period were recorded by the study physician during each day care clinic visit, regardless of their potential relation to the study intervention. After the intervention, patients were also asked to report adverse events not previously mentioned.

Perceived Stress Scale (PSS)

时间窗: up to 26 weeks (depending on chemotherapy regime)

Perceived stress was assessed by the 10-item version of the PSS, rated for the past month on a 5-point rating scale. For the summed items (range from 0 to 40) a higher total score indicates greater stress.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Dr. med. Petra Voiss

Study physician

Universität Duisburg-Essen

研究点 (2)

Loading locations...

相似试验